Yes, it's Trump's fault
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
L'Oreal says weight loss drugs are impacting beauty and skin care sales
POLL
Voting on: L'Oreal says weight loss drugs are impacting beauty and skin care sales
Poll
All Responses
Hung jury.
Yes, it's Trump's fault
No, it's not Trump's fault
Too soon to tell
0 verified votes
Yes, it's Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
No, it's not Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
A courtroom excuse or victory lap pushed to the extreme, using the same factual record.
Real event · international · 2026-10-22
Final verdict announced: October 23, 2026 at 8:02 PM ET
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
See the original report.
Original reporting
The CEO's statement highlights the impact of weight loss drugs.
Satirical commentary is temporarily unavailable. The sourced facts remain available above.